( Socials )
Case 05 · Lead Gen, Software, Social, Content · 2024 / Ongoing
The brief
Patient acquisition is the lifeblood of an online pharmacy, and the hardest thing to do well. Inspire needed new patients that were profitable and predictable, captured before they went cold, and a brand credible enough to trust with someone’s health. We were asked to generate the demand, capture it cleanly, and help convert it, all in-house.
Performance
01
18.4x
Return on ad spend over a 12-month lifetime
02
150+
Qualified new-patient leads, every month
03
85%
Sign-up rate from consented leads
04
Month 1
Profitable, before any repeat dispensing
What we shipped
A paid advertising programme engineered to acquire patients profitably and at scale. Precise targeting, conversion-led creative, relentless optimisation. 150+ qualified leads a month, and the volume scales directly with budget.
A bespoke real-time dashboard. Every lead lands the moment it is generated, already qualified with consent to sign up captured at source, so the team's call is a courtesy to confirm, not a cold sell. No leads lost in an inbox.
All of Inspire's social, run on a content calendar mapped to health awareness days and seasonal themes, matching the right service to the right patient at the right moment. A consistent, credible, health-led presence.
Every asset shot in-house to a professional standard. High-quality imagery and video of the pharmacy, the team and the service, giving Inspire a polished, trustworthy feel across every platform.
The bespoke tool
Speed-to-contact makes or breaks conversion in healthcare. Each lead flows through a purpose-built questionnaire that captures the patient’s consent to be signed up, then lands in a clean, real-time dashboard the moment it is generated. The team’s call becomes a courtesy to confirm. That is why 85% sign up.
The economics
Lifetime value : acquisition
18:1
Inspire
18 : 1
Healthy benchmark
3 : 1
Based on Inspire Pharmacy’s own performance data. Month-one profitability requires no retention assumption; the multi-month returns assume patients remain on the service, with a 12-month average patient lifetime used for illustration. As investment has grown, new-patient volume and returns have grown with it while conversion held steady.